f8k_080212.htm
United States
Securities and Exchange Commission
Washington, D.C. 20549
 
 
FORM 8-K
 
 
Current Report Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
 
 
August 2, 2012
(Date of Report)
 
 
ULTRALIFE CORPORATION
(Exact name of registrant as specified in its charter)
 
 
 
Delaware
000-20852
16-1387013
(State of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
 
2000 Technology Parkway, Newark, New York
14513
(Address of principal executive offices)
(Zip Code)
 
(315) 332-7100
(Registrant’s telephone number, including area code)
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 

 
Item 2.02
Results of Operation and Financial Condition.
 
Ultralife Corporation (NASDAQ: ULBI) reported an operating loss from continuing operations of $2.9 million on revenue of $18.7 million for the quarter ended July 1, 2012.  For the second quarter of 2011, the company reported operating income from continuing operations of $3.0 million on revenue of $43.1 million.

Revenue was $18.7 million, compared to $43.1 million for the second quarter of 2011, a 57% decline.   2011 revenue included sales, totaling $16.1 million, which did not recur in 2012.  Battery & Energy Products sales declined by $15.7 million to $15.5 million, primarily due to the absence of shipments to Defense Logistics Agency, which accounted for $4.6 million in the year-earlier period, the completion of the non-US portion of a large telematics order in 2011 for $4.0 million and a slower government and defense order rate for rechargeable and non-rechargeable batteries.  Communications Systems sales were $3.2 million, compared to $11.9 for the same period last year, a decrease of $8.7 million, reflecting primarily last year’s shipment of SATCOM systems in the amount of $7.5 million and delays in closing amplifier orders.

Gross profit was $4.5 million, or 23.9% of revenue, compared to $11.6 million, or 26.8% of revenue, for the same quarter a year ago, a decrease of 290 basis points. Battery & Energy Products’ gross margin was 24.2%, a 100 basis point improvement over the 23.2% reported last year and a 460 basis point improvement over the 19.6% reported in the first quarter reflecting the aggressive realignment of our manufacturing operations.  Communications Systems’ gross margin was 22.1%, versus 36.3% last year.  This decline was a result of sales mix, which included a higher concentration of radio accessories and legacy products versus higher volumes of amplifiers and SATCOM systems in the year-earlier period, and the recording of a reserve related to the request by a strategically important customer to rework and upgrade certain McDowell products it purchased in 2008.

Operating expenses were $7.4 million, a decrease of $1.1 million from $8.5 million a year ago, primarily due to a 19% reduction in general & administrative expenses that reflects discretionary spending cuts and overhead reductions.  In addition, ongoing disciplined spending on new product development caused research & development expenses to decrease by 7%.  Selling expenses were 8% lower as a result of reduced sales. As a percent of revenue, operating expenses were 39.6%, compared to 19.8% a year ago.

Operating loss was $2.9 million for the second quarter of 2012, compared to operating income of $3.0 million for the same period in 2011, reflecting the impact of lower sales on gross margin, offset in part by the above-mentioned actions taken by management to reduce operating expenses.

Net loss from continuing operations was $3.2 million, or $0.18 per share, compared to net income of $2.8 million, or $0.16 per share, for the second quarter of 2011.  Net income from discontinued operations was $0.0 million, or $0.00 per share, compared to a net loss of $2.3 million, or $0.13 per share, for the same quarter last year.
 
Item 9.01
Financial Statements and Exhibits.

(d)  
Exhibits.  The following exhibit is being furnished as part of this Report.
 
Exhibit
Number
Description

99.1
Press Release of Ultralife Corporation dated August 2, 2012

 
 

 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date:  August 2, 2012
 
ULTRALIFE CORPORATION
     
 
By: 
/s/ Peter F. Comerford
   
Peter F. Comerford
   
Vice President of Administration and
   
General Counsel


 
 

 
EXHIBIT INDEX
 
 
Exhibit
Number
Description

99.1
Press Release of Ultralife Corporation dated August 2, 2012
exh_991.htm
 
 
Company Contact:
Ultralife Corporation
Philip Fain
(315) 332-7100
pfain@ulbi.com
Investor Relations Contact:
Lippert/Heilshorn & Associates
Jody Burfening
(212) 838-3777
jburfening@lhai.com
 
Ultralife Corporation Reports Second Quarter Results
 
NEWARK, N.Y. – August 2, 2012 -- Ultralife Corporation (NASDAQ: ULBI) reported an operating loss from continuing operations of $2.9 million on revenue of $18.7 million for the quarter ended July 1, 2012.  For the second quarter of 2011, the company reported operating income from continuing operations of $3.0 million on revenue of $43.1 million.

“Although we anticipated a tough year-over-year comparison, delays in closing a number of Communications Systems orders caused, in large part, second quarter revenue to fall below our forecast. In addition, budget tightening by our government/defense customers continued to slow down order flow for our Battery & Energy Products,” said Michael D. Popielec, Ultralife’s president and chief executive officer.  “In view of the soft battery demand we have seen this year, we took actions in the first quarter to align capacity with demand which produced a 460 basis point sequential improvement in gross margin for Battery & Energy Products for the quarter just ended.  And despite lower earnings, thanks to assiduous working capital management, we ended the quarter with cash on hand of $4.2 million.

“Our highest priority is to remain financially healthy while demand remains soft.  To that end, we have continued to make the tough decisions, aggressively reducing overhead costs and building more efficiencies into our operations, without compromising our new product development plans,” added Popielec.   “The gestation cycles for all of our new products are on track. Field tests are underway for our GenSet Eliminator™ demonstration units and we are building additional units in the third quarter to keep up with the testing demands.  In addition to building an opportunity funnel for these new products, we continue to advance highly attractive funded opportunities, both domestic and international, in our Communications Systems business.”
 
Second Quarter 2012 Financial Results

As previously announced, Ultralife intends to divest its RedBlack Communications business.  As a result, RedBlack’s results, which had been reported in the Communications Systems segment, and related divestiture costs have been reclassified as a discontinued operation.  In addition, during the second quarter of 2011, Ultralife completed the exit of the Energy Services business.  Prior year results for the Energy Services segment are also included in discontinued operations.  All revenue, gross margin and operating expense figures presented below represent results from continuing operations.

Revenue was $18.7 million, compared to $43.1 million for the second quarter of 2011, a 57% decline.   2011 revenue included sales, totaling $16.1 million, which did not recur in 2012.  Battery & Energy Products sales declined by $15.7 million to $15.5 million, primarily due to the absence of shipments to Defense Logistics Agency, which accounted for $4.6 million in the year-earlier period, the completion of the non-US portion of a large telematics order in 2011 for $4.0 million and a slower government and defense order rate for rechargeable and non-rechargeable batteries.  Communications Systems sales were $3.2 million, compared to $11.9 for the same period last year, a decrease of $8.7 million, reflecting primarily last year’s shipment of SATCOM systems in the amount of $7.5 million and delays in closing amplifier orders.

Gross profit was $4.5 million, or 23.9% of revenue, compared to $11.6 million, or 26.8% of revenue, for the same quarter a year ago, a decrease of 290 basis points. Battery & Energy Products’ gross margin was 24.2%, a 100 basis point improvement over the 23.2% reported last year and a 460 basis point improvement over the 19.6% reported in the first quarter reflecting the aggressive realignment of our manufacturing operations.  Communications Systems’ gross margin was 22.1%, versus 36.3% last year.  This decline was a result of sales mix, which included a higher concentration of radio accessories and legacy products versus higher volumes of amplifiers and SATCOM systems in the year-earlier period, and the recording of a reserve related to the request by a strategically important customer to rework and upgrade certain McDowell products it purchased in 2008.

Operating expenses were $7.4 million, a decrease of $1.1 million from $8.5 million a year ago, primarily due to a 19% reduction in general & administrative expenses that reflects discretionary spending cuts and overhead reductions.  In addition, ongoing disciplined spending on new product development caused research & development expenses to decrease by 7%.  Selling expenses were 8% lower as a result of reduced sales. As a percent of revenue, operating expenses were 39.6%, compared to 19.8% a year ago.

Operating loss was $2.9 million for the second quarter of 2012, compared to operating income of $3.0 million for the same period in 2011, reflecting the impact of lower sales on gross margin, offset in part by the above-mentioned actions taken by management to reduce operating expenses.

Net loss from continuing operations was $3.2 million, or $0.18 per share, compared to net income of $2.8 million, or $0.16 per share, for the second quarter of 2011.  Net income from discontinued operations was $0.0 million, or $0.00 per share, compared to a net loss of $2.3 million, or $0.13 per share, for the same quarter last year.

Outlook

For 2012, management continues to expect high-single to low-double digit year-over-year revenue growth for its Communication Systems segment and China operations.  However, given the continued softness in the Battery & Energy Products segment, the company’s largest segment, management expects year-over-year total sales to decline by between 20% and 30%.  Having taken actions to reduce spending and align capacity, management believes that a return to operating profitability for the second half of 2012 is achievable with operating margin in the low- to mid-single digits.  The magnitude of the first half operating loss is expected to result in a total year operating loss.

Management cautions that the timing of orders and shipments may cause variability in quarterly results.
 
About Ultralife Corporation
 
Ultralife Corporation serves its markets with products and services ranging from portable power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.

Headquartered in Newark, New York, the company's business segments include: Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit www.ultralifecorp.com.

This press release may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The potential risks and uncertainties that could cause actual results to differ materially include: uncertain global economic conditions, increased competitive environment and pricing pressures, disruptions related to restructuring actions and delays. The Company cautions investors not to place undue reliance on forward-looking statements, which reflect the Company's analysis only as of today's date. The Company undertakes no obligation to publicly update forward-looking statements to reflect subsequent events or circumstances. Further information on these factors and other factors that could affect Ultralife's financial results is included in Ultralife's Securities and Exchange Commission (SEC) filings, including the latest Annual Report on Form 10-K.

Conference Call Information

Ultralife will hold its second quarter earnings conference call today at 10:00 AM ET. To participate, please call (800) 915-4836, identify yourself and ask for the Ultralife call. The conference call will also be broadcast live over the Internet at http://investor.ultralifecorp.com. To listen to the call, please go to the web site at least fifteen minutes early to download and install any necessary audio software. For those who cannot listen to the live webcast, a replay of the webcast will be available shortly after the call at the same location.
 
 
 

 
ULTRALIFE CORPORATION
 
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
 
(In Thousands, Except Per Share Amounts)
 
(Unaudited)
 
                         
                         
   
Three-Month Periods Ended
   
Six-Month Periods Ended
 
                         
   
July 1,
   
July 3,
   
July 1,
   
July 3,
 
   
2012
   
2011
   
2012
   
2011
 
                         
Revenues:
                       
  Battery & energy products
  $ 15,523     $ 31,239     $ 35,605     $ 55,487  
  Communications systems
    3,183       11,873       10,602       15,540  
Total revenues
    18,706       43,112       46,207       71,027  
                                 
Cost of products sold:
                               
  Battery & energy products
    11,760       23,986       27,899       45,193  
  Communications systems
    2,479       7,566       7,248       9,860  
Total cost of products sold
    14,239       31,552       35,147       55,053  
                                 
Gross profit
    4,467       11,560       11,060       15,974  
                                 
Operating expenses:
                               
  Research and development
    1,970       2,114       4,109       4,619  
  Selling, general, and administrative
    5,429       6,409       11,172       12,254  
Total operating expenses
    7,399       8,523       15,281       16,873  
                                 
Operating income (loss)
    (2,932 )     3,037       (4,221 )     (899 )
                                 
Other income (expense):
                               
  Interest income
    2       1       3       2  
  Interest expense
    (115 )     (162 )     (219 )     (318 )
  Miscellaneous
    (20 )     (9 )     32       290  
Income (loss) from continuing operations before income taxes
    (3,065 )     2,867       (4,405 )     (925 )
 
                               
Income tax provision-current
    188       63       267       67  
Income tax provision (benefit)-deferred
    (17 )     55       (5 )     109  
  Total income taxes
    171       118       262       176  
                                 
Net income (loss) from continuing operations
    (3,236 )     2,749       (4,667 )     (1,101 )
                                 
Discontinued operations:
                               
  Income (loss) from discontinued operations, net of tax
    49       (2,325 )     (22 )     (4,178 )
                                 
Net income (loss)
    (3,187 )     424       (4,689 )     (5,279 )
                                 
Net (income) loss attributable to noncontrolling interest
    20       15       20       28  
                                 
Net income (loss) attributable to Ultralife
  $ (3,167 )   $ 439     $ (4,669 )   $ (5,251 )
                                 
Other comprehensive income (loss):
                               
  Foreign currency translation adjustments
    (25 )     60       123       287  
                                 
Comprehensive income (loss) attributable to Ultralife
  $ (3,192 )   $ 499     $ (4,546 )   $ (4,964 )
                                 
                                 
Net income (loss) attributable to Ultralife common shareholders - basic
                         
  Continuing operations
  $ (0.18 )   $ 0.16     $ (0.27 )   $ (0.06 )
  Discontinued operations
  $ 0.00     $ (0.13 )   $ (0.00 )   $ (0.24 )
  Total
  $ (0.18 )   $ 0.03     $ (0.27 )   $ (0.30 )
Net income (loss) attributable to Ultralife common shareholders - diluted
                         
  Continuing operations
  $ (0.18 )   $ 0.16     $ (0.27 )   $ (0.06 )
  Discontinued operations
  $ 0.00     $ (0.13 )   $ (0.00 )   $ (0.24 )
  Total
  $ (0.18 )   $ 0.03     $ (0.27 )   $ (0.30 )
                                 
                                 
Weighted average shares outstanding - basic
    17,396       17,296       17,376       17,286  
Weighted average shares outstanding - diluted
    17,396       17,308       17,376       17,286  
 
 
 

 
ULTRALIFE CORPORATION
           
 CONSOLIDATED BALANCE SHEETS
           
(In Thousands, Except Per Share Amounts)
           
(unaudited)
           
             
             
   
July 1,
   
December 31,
 
ASSETS
 
2012
   
2011
 
             
Current assets:
           
   Cash and cash equivalents
  $ 4,178     $ 5,486  
   Trade accounts receivable, net
    15,611       19,903  
   Inventories
    33,692       34,967  
   Prepaid expenses and other current assets
    3,025       3,877  
     Total current assets
    56,506       64,233  
                 
Property and equipment
    12,714       12,588  
                 
Other assets:
               
   Goodwill, intangible and other assets
    23,771       23,994  
                 
Total Assets
  $ 92,991     $ 100,815  
                 
LIABILITIES AND SHAREHOLDERS' EQUITY
               
                 
Current liabilities:
               
   Short-term debt and current portion of long-term debt
  $ 357     $ -  
   Accounts payable
    10,748       13,766  
   Other current liabilities
    7,924       9,392  
      Total current liabilities
    19,029       23,158  
                 
Long-term liabilities:
               
    Other long-term liabilities
    4,517       4,431  
                 
Shareholders' equity:
               
  Ultralife equity:
               
    Common stock, par value $0.10 per share
    1,881       1,874  
    Capital in excess of par value
    173,087       172,309  
    Accumulated other comprehensive loss
    (862 )     (985 )
    Accumulated deficit
    (96,949 )     (92,280 )
 
    77,157       80,918  
    Less -- Treasury stock, at cost
    7,658       7,658  
      Total Ultralife equity
    69,499       73,260  
  Noncontrolling interest
    (54 )     (34 )
      Total shareholders' equity
    69,445       73,226  
                 
Total Liabilities and Shareholders' Equity
  $ 92,991     $ 100,815